Drawing for NOKSIPZA

USPTO serial 79205069

NOKSIPZA

Reviewed by CopyMark Law Group

Reg. 5319606Status 709
Filing date
Status date
Registration date
Oct 31, 2017
Examiner
MCCRAY, RENEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOKSIPZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

Yoon S. Ham HAUPTMAN HAM, LLP2318 Mill RoadSuite 1400Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; vaccines against flu; veterinary vaccines; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of the immune system by regulating it; virucides; vaccine preparations; adrenal hormone preparations; pharmaceutical preparations for use in gynecology; pharmaceutical preparations for use in urology; vitamin tablets; pharmaceutical preparations for wounds; cellular function activating agents for medical purposes; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations, namely, antioxidants; veterinary diagnostic reagents for use in veterinary genetic testing; pharmaceutical preparations for the treatment of cardiovascular disease; ophthalmic preparations; ophthalmologic preparations; eye drops; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical agents for epidermis; sanitary sterilising preparations; medicines for the treatment of gastrointestinal diseases; medicated mouth care and treatment preparations; parasiticides for medical use; diagnostic preparations for medical or veterinary purposes; cleansing solutions for medical use; cardiovascular agents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; hemostatics for medical purposes; antibacterial substances for medical purposes; diuretics; insulin; human vaccine preparations; general anesthetics; pharmaceutical preparations for the treatment of auto-immune diseases; multivitamin preparations; pharmaceutical preparations acting on the central nervous system; styptic pencils for medical purposes; pharmaceutical preparations for treating asthma; pharmaceutical solutions used in dialysis; penicillin preparations; antimicrobials for dermatologic use; pharmaceutical preparations for treating skin disorders; contraceptive preparations; antihypertensives; anti-diabetic pharmaceuticals; antitoxins; antivirals; antiarrhythmic agents; antibiotic preparations; anti-cancer preparations; anticoagulants; tumor suppressing agents; antifungal preparations; anti-dermoinfectives; antidotes; antipyretic analgesics; vasoconstrictors; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; mixed antibiotic preparations; mixed hormone preparations; chemotherapeutics; pharmaceutical preparations for use in discouraging the smoking habit, namely, smoking cessation preparationsSECTION 71 - CANCELLED—
035Retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging productsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 8, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 8, 2025INPCINVALIDATION PROCESSED—
Jan 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 17, 2024C71TCANCELLED SECTION 71—
Oct 31, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 13, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 12, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 12, 2018FIMPFINAL DISPOSITION PROCESSED—
Jan 31, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 31, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2017GPNXNOTIFICATION PROCESSED BY IB—
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 10, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 6, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 5, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 5, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2017ALIEASSIGNED TO LIE—
Jun 1, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 5, 2017RFNTREFUSAL PROCESSED BY IB—
Apr 19, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 19, 2017RFRRREFUSAL PROCESSED BY MPU—
Apr 18, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 16, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 15, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2017DOCKASSIGNED TO EXAMINER—
Apr 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance